Written question asked by Lord Warner (Crossbench) on Tuesday, 14 May 2024, in the House of Lords. It was due for an answer on Wednesday, 29 May 2024. It was answered by Lord Markham (Conservative) on Tuesday, 21 May 2024 on behalf of the Department of Health and Social Care.
NHS: Drugs
- Question
-
To ask His Majesty's Government what assessment they have made of the impact of the NHS England uniform pricing policy on patients' access to innovative medicines.
- Answer
-
NHS England has successfully secured patient access to a number of innovative medicines under its policy of uniform pricing. European industry data from April 2023 showed that for every four treatments available in Europe, there is an additional medicine available in England, and a quarter more cancer drugs available in England compared to the European average.
Secondary information
- Type
- Written question
- Reference
- HL4654
- Session
- 2023-24
- Subjects
- Drugs Innovation NHS Prices
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-06 11:48:50 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL4654
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL4654
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2023-24/HL4654